Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia.
Saved in:
| Title: | Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia. |
|---|---|
| Authors: | Williams LJ; The Walter and Eliza Hall Institute for Medical Research Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Melbourne VIC Australia., Li-Wai-Suen CS; The Walter and Eliza Hall Institute for Medical Research Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Melbourne VIC Australia., Garnham AL; The Walter and Eliza Hall Institute for Medical Research Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Melbourne VIC Australia., Bader SM; The Walter and Eliza Hall Institute for Medical Research Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Melbourne VIC Australia., Tam CS; The Alfred Hospital Melbourne VIC Australia.; Faculty of Medicine, Nursing and Health Sciences Monash University Clayton VIC Australia., Whitechurch A; Department of Clinical Hematology The Royal Melbourne Hospital and Peter MacCallum Cancer Centre Melbourne VIC Australia., Slavin MA; Department of Infectious Diseases Peter MacCallum Cancer Centre Melbourne VIC Australia.; Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne VIC Australia.; National Centre for Infections in Cancer Peter MacCallum Cancer Centre Melbourne VIC Australia.; Victorian Infectious Diseases Service Royal Melbourne Hospital Melbourne VIC Australia., Doerflinger M; The Walter and Eliza Hall Institute for Medical Research Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Melbourne VIC Australia., Teh BW; Department of Infectious Diseases Peter MacCallum Cancer Centre Melbourne VIC Australia.; Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne VIC Australia.; National Centre for Infections in Cancer Peter MacCallum Cancer Centre Melbourne VIC Australia. |
| Source: | Clinical & translational immunology [Clin Transl Immunology] 2025 Aug 03; Vol. 14 (8), pp. e70049. Date of Electronic Publication: 2025 Aug 03 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc Country of Publication: Australia NLM ID: 101638268 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0068 (Print) Linking ISSN: 20500068 NLM ISO Abbreviation: Clin Transl Immunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40766049 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Williams+LJ%22">Williams LJ</searchLink>; The Walter and Eliza Hall Institute for Medical Research Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Melbourne VIC Australia.<br /><searchLink fieldCode="AU" term="%22Li-Wai-Suen+CS%22">Li-Wai-Suen CS</searchLink>; The Walter and Eliza Hall Institute for Medical Research Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Melbourne VIC Australia.<br /><searchLink fieldCode="AU" term="%22Garnham+AL%22">Garnham AL</searchLink>; The Walter and Eliza Hall Institute for Medical Research Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Melbourne VIC Australia.<br /><searchLink fieldCode="AU" term="%22Bader+SM%22">Bader SM</searchLink>; The Walter and Eliza Hall Institute for Medical Research Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Melbourne VIC Australia.<br /><searchLink fieldCode="AU" term="%22Tam+CS%22">Tam CS</searchLink>; The Alfred Hospital Melbourne VIC Australia.; Faculty of Medicine, Nursing and Health Sciences Monash University Clayton VIC Australia.<br /><searchLink fieldCode="AU" term="%22Whitechurch+A%22">Whitechurch A</searchLink>; Department of Clinical Hematology The Royal Melbourne Hospital and Peter MacCallum Cancer Centre Melbourne VIC Australia.<br /><searchLink fieldCode="AU" term="%22Slavin+MA%22">Slavin MA</searchLink>; Department of Infectious Diseases Peter MacCallum Cancer Centre Melbourne VIC Australia.; Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne VIC Australia.; National Centre for Infections in Cancer Peter MacCallum Cancer Centre Melbourne VIC Australia.; Victorian Infectious Diseases Service Royal Melbourne Hospital Melbourne VIC Australia.<br /><searchLink fieldCode="AU" term="%22Doerflinger+M%22">Doerflinger M</searchLink>; The Walter and Eliza Hall Institute for Medical Research Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Melbourne VIC Australia.<br /><searchLink fieldCode="AU" term="%22Teh+BW%22">Teh BW</searchLink>; Department of Infectious Diseases Peter MacCallum Cancer Centre Melbourne VIC Australia.; Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne VIC Australia.; National Centre for Infections in Cancer Peter MacCallum Cancer Centre Melbourne VIC Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101638268%22">Clinical & translational immunology</searchLink> [Clin Transl Immunology] 2025 Aug 03; Vol. 14 (8), pp. e70049. <i>Date of Electronic Publication: </i>2025 Aug 03 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Australia%2C+Ltd%2E+on+behalf+of+Australasian+Society+for+Immunology+Inc%22">John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101638268 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2050-0068 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220500068%22">20500068 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Immunology <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40766049 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cti2.70049 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70049 Titles: – TitleFull: Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Williams LJ – PersonEntity: Name: NameFull: Li-Wai-Suen CS – PersonEntity: Name: NameFull: Garnham AL – PersonEntity: Name: NameFull: Bader SM – PersonEntity: Name: NameFull: Tam CS – PersonEntity: Name: NameFull: Whitechurch A – PersonEntity: Name: NameFull: Slavin MA – PersonEntity: Name: NameFull: Doerflinger M – PersonEntity: Name: NameFull: Teh BW IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 08 Text: 2025 Aug 03 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2050-0068 Numbering: – Type: volume Value: 14 – Type: issue Value: 8 Titles: – TitleFull: Clinical & translational immunology Type: main |
| ResultId | 1 |
